MPLX LP has a consensus price target of $43.13 based on the ratings of 15 analysts. The high is $49 issued by UBS on April 12, 2024. The low is $36 issued by Citigroup on July 12, 2023. The 3 most-recent analyst ratings were released by Barclays, JP Morgan, and Truist Securities on July 12, 2024, May 3, 2024, and May 2, 2024, respectively. With an average price target of $46.33 between Barclays, JP Morgan, and Truist Securities, there's an implied 6.51% upside for MPLX LP from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/12/2024 | Buy Now | 3.45% | Barclays | Christine Cho | $43 → $45 | Maintains | Overweight | Get Alert |
05/03/2024 | Buy Now | 5.75% | JP Morgan | Jeremy Tonet | $45 → $46 | Maintains | Overweight | Get Alert |
05/02/2024 | Buy Now | 10.34% | Truist Securities | Neal Dingmann | $43 → $48 | Maintains | Buy | Get Alert |
05/01/2024 | Buy Now | 8.05% | Stifel | Selman Akyol | $45 → $47 | Maintains | Buy | Get Alert |
04/12/2024 | Buy Now | 12.64% | UBS | Brian Reynolds | $46 → $49 | Maintains | Buy | Get Alert |
04/05/2024 | Buy Now | -1.15% | Barclays | Christine Cho | $40 → $43 | Maintains | Overweight | Get Alert |
03/01/2024 | Buy Now | 5.75% | UBS | Joseph Parkhill | $44 → $46 | Maintains | Buy | Get Alert |
01/31/2024 | Buy Now | 3.45% | Raymond James | Justin Jenkins | $44 → $45 | Maintains | Outperform | Get Alert |
01/31/2024 | Buy Now | 5.75% | RBC Capital | Elvira Scotto | $45 → $46 | Maintains | Outperform | Get Alert |
10/06/2023 | Buy Now | -8.05% | Goldman Sachs | John Mackay | → $40 | Reinstates | → Buy | Get Alert |
08/16/2023 | Buy Now | -3.45% | Stifel | Selman Akyol | $40 → $42 | Maintains | Buy | Get Alert |
07/21/2023 | Buy Now | 1.15% | Raymond James | Justin Jenkins | $42 → $44 | Maintains | Outperform | Get Alert |
07/20/2023 | Buy Now | -3.45% | Morgan Stanley | Robert Kad | $42 → $42 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
07/12/2023 | Buy Now | -17.24% | Citigroup | Spiro Dounis | → $36 | Reiterates | Neutral → Neutral | Get Alert |
07/11/2023 | Buy Now | -3.45% | Morgan Stanley | Robert Kad | $42 → $42 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
05/03/2023 | Buy Now | -3.45% | Raymond James | Justin Jenkins | $40 → $42 | Maintains | Outperform | Get Alert |
04/25/2023 | Buy Now | -3.45% | Morgan Stanley | Robert Kad | $41 → $42 | Maintains | Equal-Weight | Get Alert |
04/21/2023 | Buy Now | -8.05% | Raymond James | Justin Jenkins | $41 → $40 | Maintains | Outperform | Get Alert |
04/05/2023 | Buy Now | -12.64% | Barclays | Theresa Chen | $37 → $38 | Maintains | Overweight | Get Alert |
03/14/2023 | Buy Now | -5.75% | JP Morgan | Jeremy Tonet | $37 → $41 | Upgrade | Neutral → Overweight | Get Alert |
02/07/2023 | Buy Now | -19.54% | Citigroup | Spiro Dounis | $33.5 → $35 | Maintains | Neutral | Get Alert |
02/01/2023 | Buy Now | -5.75% | Raymond James | Justin Jenkins | $40 → $41 | Maintains | Outperform | Get Alert |
01/09/2023 | Buy Now | -5.75% | Morgan Stanley | Robert Kad | $39 → $41 | Maintains | Equal-Weight | Get Alert |
01/09/2023 | Buy Now | -17.24% | Wolfe Research | Keith Stanley | → $36 | Upgrade | Peer Perform → Outperform | Get Alert |
12/09/2022 | Buy Now | -22.99% | Citigroup | Spiro Dounis | → $33.5 | Initiates | → Neutral | Get Alert |
11/07/2022 | Buy Now | -8.05% | Wells Fargo | Michael Blum | $41 → $40 | Maintains | Overweight | Get Alert |
11/02/2022 | Buy Now | -8.05% | Raymond James | Justin Jenkins | $39 → $40 | Maintains | Outperform | Get Alert |
07/08/2022 | Buy Now | -8.05% | UBS | Joseph Parkhill | $41 → $40 | Maintains | Buy | Get Alert |
05/02/2022 | Buy Now | -14.94% | Truist Securities | Neal Dingmann | → $37 | Assumes | → Buy | Get Alert |
04/28/2022 | Buy Now | -5.75% | Wells Fargo | Michael Blum | $37 → $41 | Maintains | Overweight | Get Alert |
04/26/2022 | Buy Now | -10.34% | Morgan Stanley | Robert Kad | $37 → $39 | Maintains | Equal-Weight | Get Alert |
04/20/2022 | Buy Now | -10.34% | Raymond James | Justin Jenkins | $37 → $39 | Maintains | Outperform | Get Alert |
02/03/2022 | Buy Now | -14.94% | Raymond James | Justin Jenkins | $35 → $37 | Maintains | Outperform | Get Alert |
01/24/2022 | Buy Now | -19.54% | Raymond James | Justin Jenkins | $34 → $35 | Maintains | Outperform | Get Alert |
01/18/2022 | Buy Now | -1.15% | B of A Securities | Chase Mulvehill | $39 → $43 | Maintains | Buy | Get Alert |
12/16/2021 | Buy Now | -19.54% | Wells Fargo | Michael Blum | — | Maintains | Overweight | Get Alert |
11/23/2021 | Buy Now | -14.94% | Morgan Stanley | Robert Kad | — | Maintains | Equal-Weight | Get Alert |
10/19/2021 | Buy Now | -21.84% | Barclays | Christine Cho | — | Maintains | Overweight | Get Alert |
10/07/2021 | Buy Now | -24.14% | Barclays | Theresa Chen | — | Maintains | Overweight | Get Alert |
The latest price target for MPLX (NYSE:MPLX) was reported by Barclays on July 12, 2024. The analyst firm set a price target for $45.00 expecting MPLX to rise to within 12 months (a possible 3.45% upside). 11 analyst firms have reported ratings in the last year.
The latest analyst rating for MPLX (NYSE:MPLX) was provided by Barclays, and MPLX maintained their overweight rating.
The last upgrade for MPLX LP happened on March 14, 2023 when JP Morgan raised their price target to $41. JP Morgan previously had a neutral for MPLX LP.
There is no last downgrade for MPLX.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MPLX, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MPLX was filed on July 12, 2024 so you should expect the next rating to be made available sometime around July 12, 2025.
While ratings are subjective and will change, the latest MPLX (MPLX) rating was a maintained with a price target of $43.00 to $45.00. The current price MPLX (MPLX) is trading at is $43.50, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.